نتائج البحث - "Mustafa Erman"

المساهمون: Medical Oncology, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Petrylak, Dp, de Wit, R, Chi, Kn, Drakaki, A, Sternberg, Cn, Nishiyama, H, Castellano, D, Hussain, Sa, Flechon, A, Bamias, A, Yu, Ey, van der Heijden, M, Matsubara, N, Alekseev, B, Necchi, A, Geczi, L, Ou, Yc, Coskun, H, Su, Wp, Bedke, J, Gakis, G, Percent, Ij, Lee, Jl, Tucci, M, Semenov, A, Laestadius, F, Peer, A, Tortora, G, Safina, S, del Muro, Xg, Rodriguez-Vida, A, Cicin, I, Harputluoglu, H, Tagawa, St, Vaishampayan, U, Aragon-Ching, Jb, Hamid, O, Liepa, Am, Wijayawardana, S, Russo, F, Walgren, Ra, Zimmermann, Ah, Hozak, Rr, Bell-McGuinn, Km, Powles, T, Graduate School

المصدر: Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group

مصطلحات موضوعية: Male, 0301 basic medicine, MULTICENTER, Docetaxel, Gastroenterology, ANGIOGENESIS, VINFLUNINE, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Neoplasm Metastasis, education.field_of_study, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, Prognosis, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, EXPRESSION, Urologic Neoplasms, medicine.medical_specialty, BEVACIZUMAB, Population, BLADDER-CANCER, Neutropenia, Antibodies, Monoclonal, Humanized, Placebo, Ramucirumab, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, Neoplasm Invasiveness, education, Survival rate, Aged, Platinum, Salvage Therapy, Carcinoma, Transitional Cell, business.industry, medicine.disease, ATEZOLIZUMAB, 030104 developmental biology, ENDOTHELIAL GROWTH-FACTOR, business, Febrile neutropenia, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf61e6c114a1ba3c5764d0e77ad9425aTest
https://doi.org/10.1016/s1470-2045Test(19)30668-0

65

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN)

المؤلفون: Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, György Losonczy, Nikolay V Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan W Goldman, Emilio Batagelj, Ignacio Casarini, Anea Viviana Pastor, Susana Noemi Sena, Juan Jose Zarba, Otto Burghuber, Sylvia Hartl, Bernd Lamprecht, Michael Studnicka, Luis Alberto Schlittler, Fabricio Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Colagiovanni Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Serodio da Rocha Baldotto, Claudia Sette, Mauro Zukin, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Wei Li, Zongan Liang, Zhong Lin, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Vitezslav Kolek, Leona Koubkova, Jaromir Roubec, Jana Skrickova, Milada Zemanova, Christos Chouaid, Werner Hilgers, Hervé Lena, Denis Moro-Sibilot, Gilles Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohe, Eckart Laack, Susanne Lang, Jens Panse, Christian Schulz, Krisztina Bogos, Eszter Csánky, Anea Fülöp, Zsolt Horváth, Judit Kósa, Ibolya Laczó, Gábor Pajkos, Zsuzsanna Pápai, Zsolt Pápai Székely, Veronika Sárosi, Attila Somfay, Éva Somogyiné Ezer, Anás Telekes, Jair Bar, Maya Gottfried, Norman Isaac Heching, Alona Zer Kuch, Roberta Bartolucci, Anna Cecilia Bettini, Angelo Delmonte, Marina Chiara Garassino, Mauro Minelli, Fausto Roila, Shinji Atagi, Koichi Azuma, Hisatsugu Goto, Koichi Goto, Yu Hara, Hidetoshi Hayashi, Toyoaki Hida, Kenya Kanazawa, Shintaro Kanda, Young Hak Kim, Shoichi Kuyama, Tadashi Maeda, Masahiro Morise, Yasuharu Nakahara, Makoto Nishio, Naoyuki Nogami, Isamu Okamoto, Haruhiro Saito, Masahiro Shinoda, Shigeki Umemura, Tatsuya Yoshida, Niels Claessens, Robin Cornelissen, Lizza Heniks, Jeroen Hiltermann, Egbert Smit, Agnes Staal van den Brekel, Dariusz Kowalski, Slawomir Mańdziuk, Robert Mróz, Marek Wojtukiewicz, Tudor Ciuleanu, Doina Ganea, Anei Ungureanu, Alexander Luft, Vladimir Moiseenko, Dina Sakaeva, Alexey Smolin, Alexander Vasilyev, Lyubov Vladimirova, Igor Anasina, Jozef Chovanec, Pavol Demo, Robert Godal, Peter Kasan, Marian Stresko, Michal Urda, Eun Kyung Cho, Joo-Hang Kim, Sang-We Kim, Gyeong-Won Lee, Jong-Seok Lee, Ki Hyeong Lee, Kyung Hee Lee, Yun Gyoo Lee, Maria Amelia Insa Molla, Manuel Domine Gomez, Juan Ignacio Delgado Mingorance, Dolores Isla Casado, Marta Lopez Brea, Margarita Majem Tarruella, Teresa Morán Bueno, Alejano Navarro Mendivil, Luis Paz-Ares Rodríguez, Santiago Ponce Aix, Maria Rosario Garcia Campelo, Gee-Chen Chang, Yen-Hsun Chen, Chao-Hua Chiu, Te-Chun Hsia, Kang-Yun Lee, Chien-Te Li, Chin-Chou Wang, Yu-Feng Wei, Shang-Yin Wu, Ahmet Alacacıoğlu, Irfan Çiçin, Ahmet Demirkazik, Mustafa Erman, Tuncay Göksel, Hryhoriy Adamchuk, Oleksii Kolesnik, Anna Kryzhanivska, Yuriv Ostapenko, Serhii Shevnia, Yaroslav Shparyk, Grygorii Ursol, Nataliia Voitko, Ihor Vynnychenko, Sunil Babu, Anne Chiang, Winston Chua, Shaker Dakhil, Afshin Dowlati, Basir Haque, Rodney Jamil, Jeanna Knoble, Shailena Lakhanpal, Kailhong Mi, Petros Nikolinakos, Steven Powell, Helen Ross, Eric Schaefer, Jeffrey Schneider, Joseph Spahr, David Spigel, Joseph Stilwill, Christopher Sumey, Michael Williamson

المصدر: The Lancet. 394(10212):1929-1939

مصطلحات موضوعية: Male, medicine.medical_specialty, Lung Neoplasms, Durvalumab, Population, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Gastroenterology, Drug Administration Schedule, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, Antineoplastic Agents, Immunological, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, 030212 general & internal medicine, Progression-free survival, education, Etoposide, Aged, education.field_of_study, Performance status, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, Interim analysis, Antineoplastic Agents, Phytogenic, Small Cell Lung Carcinoma, Progression-Free Survival, chemistry, Female, Cisplatin, Prophylactic cranial irradiation, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317c16284ac18a580a61a7c59b1e6e37Test
http://www.scopus.com/inward/record.url?scp=85075219567&partnerID=8YFLogxKTest

66

Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better

المؤلفون: Deniz Can Guven, Gurkan Guner, Mutlu Hayran, Mustafa Erman, Omer Dizdar

المصدر: Journal of Oncological Sciences, Vol 5, Iss 2, Pp 45-48 (2019)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb48a29a82b2977e3e0bb6d98a479586Test
http://www.sciencedirect.com/science/article/pii/S2452336418300967Test

67

Blood based biomarkers as predictive factors for hyperprogression

المؤلفون: Feride Yilmaz, Deniz Can Guven, Mustafa Erman, Saadettin Kilickap, Sercan Aksoy, Serkan Yasar, Oktay Halit Aktepe, Hasan Cagri Yildirim, Suayib Yalcin, Hakan Taban

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Blood based biomarkers, Internal medicine, medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bbf4cb0052feeb1580aebe2e84400febTest
https://doi.org/10.21203/rs.3.rs-991928/v1Test

68

THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy

المؤلفون: Oktay Halit Aktepe, Fatma Gundogdu, Mustafa Erman, Taha Koray Sahin, Deniz Yuce, Kemal Kosemehmetoglu, Omer Dizdar, Sercan Aksoy, Neyran Kertmen, Suayib Yalcin, Deniz Can Guven, Haci Hasan Yeter

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1669c58e0baf57fea8fa74edbc95130Test
https://avesis.gazi.edu.tr/publication/details/527723d6-78ac-4486-a3f3-5a21fc72138a/oaiTest

69

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

المساهمون: İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fatma Paksoy Türköz / 0000-0002-2314-263X, Saadettin Kılıçkap / 0000-0003-1637-7390, Paksoy Türköz, Fatma, Kılıçkap, Saadettin

مصطلحات موضوعية: 0301 basic medicine, Oncology, Survival, retrospective study, Trial, hazard ratio, primary tumor, 0302 clinical medicine, Surgical oncology, transitional cell carcinoma, creatinine clearance, Atezolizumab, Cancer, Univariate analysis, adult, Hazard ratio, Hematology, General Medicine, Bladder Cancer, univariate analysis, aged, female, multivariate analysis, 030220 oncology & carcinogenesis, Immunotherapy, Plus, medicine.medical_specialty, Metastatic Urothelial Carcinoma, overall survival, tumor localization, Renal function, medical record, cancer prognosis, Article, cancer growth, 03 medical and health sciences, evaluation study, male, Internal medicine, medicine, follow up, human, lymphocyte count, Bladder cancer, hemoglobin blood level, Performance status, ECOG Performance Status, business.industry, neutrophil count, Urothelial Carcinoma, hemoglobin, medicine.disease, major clinical study, neutrophil lymphocyte ratio, liver metastasis, 030104 developmental biology, Surgery, Therapy, Cisplatin, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad0808c1ae34df687e136a5aa5ec7caTest
https://avesis.deu.edu.tr/publication/details/8d62a86a-0e4f-4339-9426-b0070cd55957/oaiTest

70

Response to first line chemotherapy regimen is associated with efficacy of Immune Checkpoint Blockade Therapies in Patients with Metastatic Urothelial Carcinoma

المؤلفون: Deniz Tural, Fatih Selçukbiricik, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Mustafa Erman, Hasan Şenol Coşkun, Mehmet Artaç, Saadettin Kılıçkap

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1a4dc0014a80401749b054d406c8987fTest
https://doi.org/10.21203/rs.3.rs-712822/v1Test

تنقيح النتائج